Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The innate immune system is the body's first line of defense against pathogens and foreign substances. It is a nonspecific, rapid-response system that acts within minutes to hours after exposure to an invader, in contrast to the slower adaptive immune response which takes days to weeks. The innate immune system is present from birth and does not require prior exposure or "training" to recognize threats. It comprises physical barriers, chemical barriers, cellular components (neutrophils, macrophages, dendritic cells, natural killer cells, mast cells, eosinophils, basophils), and humoral components (complement proteins, interferons, interleukin-1). It relies on pattern recognition receptors (PRRs) such as toll-like receptors (TLRs), NOD-like receptors (NLRs), and RIG-I-like receptors (RLRs) to detect pathogen-associated molecular patterns (PAMPs) and damage-associated molecular patterns (DAMPs).
N/A
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Innate Immune System (N/A).